Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
$920K-35.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$12.12M+3.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$2.4M+10.3%
Alumis Inc. logo
Alumis Inc.ALMS
$4.44M+74.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.56M+1.4%

Other financials

Income statement

See full
Revenue-—
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.96B+1,120%
Enterprise value$5.91B+1,289%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0×0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemMarch 31, 2026December 31, 2025
Current liabilities:
Accounts payable$3,662$4,155
Accrued expenses and other current liabilities9,28710,591
Operating lease liability, current680619
Related party accounts payable and other current liabilities3,0049
Total current liabilities16,63315,374
Operating lease liability, non-current1,1271,313
Total liabilities17,76016,687

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s operating lease liabilities (current)?
Oruka Therapeutics, Inc. (ORKA) reported operating lease liabilities (current) of $680K in Q1 2026.
How has Oruka Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
Oruka Therapeutics, Inc.'s operating lease liabilities (current) increased by 140.3% year-over-year, from $283K to $680K.
What is the long-term trend for Oruka Therapeutics, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 72.1% compound annual growth rate (CAGR), from $41K to $619K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Oruka Therapeutics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude